Abstract
We report two platinum(iv) complexes conjugated with a vitamin E analog, α-tocopherol succinate (α-TOS). One of the conjugates displays the activity of both cisplatin and α-TOS in cancer cells, causing damage to DNA and mitochondria simultaneously. Accordingly, it serves as a promising dual-targeting anticancer agent.
| Original language | English |
|---|---|
| Pages (from-to) | 2465-2468 |
| Number of pages | 4 |
| Journal | Chemical communications (Cambridge, England) |
| Volume | 50 |
| Issue number | 19 |
| DOIs | |
| Publication status | Published - 7 Mar 2014 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Conjugation of vitamin e analog α-TOS to Pt(iv) complexes for dual-targeting anticancer therapy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver